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Covalently closed circular DNA (cccDNA) forms a template for the replication of hepatitis B virus
(HBV) and duck HBV (DHBV). Recent studies suggest that activation-induced cytidine deaminase
(AID) functions in innate immunity, although its molecular mechanism of action remains unclear,
particularly regarding HBV restriction. Here we demonstrated that overexpression of chicken AID
caused hypermutation and reduction of DHBV cccDNA levels. Inhibition of uracil-DNA glycosylase
(UNG) by UNG inhibitor protein (UGI) abolished AID-induced cccDNA reduction, suggesting that
the AID/UNG pathway triggers the degradation of cccDNA via cytosine deamination and uracil
excision.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction model has been commonly used to study HBV replication [2]. Re-The covalently closed circular DNA (cccDNA) of the hepatitis B
virus (HBV) plays an essential role in chronic hepatitis. cccDNA ex-
ists as an episome in the nucleus of infected hepatocytes and tran-
scribes all viral RNAs, including pregenomic (pg) RNA. pgRNA is
assembled into the nucleocapsid (NC) in the cytoplasm and is then
converted into a relaxed circular DNA (rcDNA) by viral polymerase
activity. Mature NCs are secreted after combining with envelope
proteins or translocated to the nucleus. In the nucleus, the rcDNA
is again converted into cccDNA for the next replication cycle. Only
one or a few copies of cccDNA per infected cell are stably main-
tained by an unknown mechanism [1].
Despite the crucial role of cccDNA in viral persistence, little is
known about the host factors that target this viral nuclear interme-
diate owing to the absence of an efﬁcient experimental system that
can produce HBV cccDNA at a level sufﬁcient for analysis. In view
of the limitation of HBV in vitro systems, the duck HBV (DHBV)cently, we reported that an anti-viral factor APOBEC3G (A3G) in-
duces hypermutation on DHBV cccDNA [3]. A3G belongs to the
APOBEC (apolipoprotein B mRNA-editing catalytic polypeptide)
family of proteins. In humans, this family comprises at least 11
members including AID and APOBEC-1, -2, -3A, -3B, -3C, -3DE,
-3F, -3G, -3H and -4. These AID/APOBEC proteins have enzymatic
activity that can deaminate a cytosine base in DNA and/or RNA,
thereby generating a uracil base. A3G is known to restrict the rep-
lication of retroviruses, including human immunodeﬁciency virus
type 1 (HIV-1), HBV and retrotransposable elements [4–6]. AID
was initially identiﬁed as an essential factor for class-switch
recombination (CSR) and somatic hypermutation (SHM) of immu-
noglobulin genes in B cells [7,8]. It was also found that AID is ex-
pressed in response to cytokine stimulation in human
hepatocytes [9] and HBV patients [10], induces HBV hypermuta-
tion in NC-DNA [10] and pgRNA [11] and restricts viral replication
[12]. It remains to be established whether AID targets hepadnavi-
rus cccDNA.
UNG is a host nuclear factor that removes uracil bases from
uracilated DNA and initiates base excision repair (BER), resulting
in DNA repair or cleavage [13]. The involvement of UNG activity
in A3G-induced viral restriction has been vigorously studied in
the HIV ﬁeld, but remains a subject of debate [14–17]. We previ-
ously demonstrated that UNG repairs DHBV cccDNA hypermuta-
tion induced by A3G [3]. The involvement of UNG in the
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initiate CSR and SHM by coupling with downstream UNG-directed
BER pathways [13,18].
Here we investigated the effects of chicken AID on DHBV repli-
cation using an in vitro DHBV replication system with a chicken
hepatoma cell line LMH, which we utilized to analyse cccDNA for-
mation and function [2,19,20]. We found that the expression of
chicken AID in LMH cells resulted in the reduction of DHBV NC-
DNA and cccDNA. Furthermore, UNG inhibition abolished AID-in-
duced reduction of cccDNA but not NC-DNA, suggesting that viral
DNA degradation is induced by the AID/UNG pathway in the
nucleus.
2. Materials and methods
2.1. Plasmids
The DHBV replicon plasmid pCSD3.5DS [21] and UGI expression
vector pIRES-UGI [3] were described previously. The pCSD3.5DS
plasmid produces a DHBV surface-deﬁcient mutant that accumu-
lates cccDNAs more efﬁciently than wild-type DHBV [20,21]. Other
expression vectors are described in the Supplementary methods.
2.2. Cell culture and transfection
LMH cells were maintained in Dulbecco’s modiﬁed Eagle med-
ium (DMEM; Sigma, St. Louis, MO, USA) containing 10% foetal bo-
vine serum, 100 U/mL penicillin and 100 lg/mL streptomycin.
Plasmid transfection was performed using Fugene 6 (Roche, Basel,
Switzerland), according to the manufacturer’s instructions. The to-
tal DNA amount (6 lg for a 60-mm dish) for each transfection was
kept constant by adding mock vector as needed. The ER-fusion pro-
tein that was expressed as an inactive form was activated by
tamoxifen (OHT, Wako Pure Chemical Industries, Osaka, Japan)
treatment [22]. In the subcellular localization experiments of GFP
fusion proteins, cells were treated with 10 ng/mL leptomycin B
(LMB, Sigma) for 4 h.
2.3. Puriﬁcation of viral DNAs
Cells were lysed in 0.5% NP40 lysis buffer, and nuclei were col-
lected by centrifugation to separate the cytoplasmic and nuclear
fractions. Cytoplasmic supernatants were treated with DNase I
and RNase A and digested with proteinase K and sodium dodecyl
sulphate (SDS) to extract viral NC-DNA. A modiﬁed Hirt extraction
procedure was used to extract cccDNA from the nuclear fraction
[3]. The nuclear pellet was lysed in 50 mM Tris–HCl (pH 7.5),
10 mM EDTA and 2% SDS. After a 20-min incubation at room tem-
perature, 0.5 M KC1 was added to the lysate and incubated at 4C
overnight. All puriﬁed DNA solutions were treated with Dpnl
restriction enzyme to digest any transfected plasmid DNA.
2.4. Mutation analysis
Hypermutation was detected using differential DNA denatur-
ation PCR (3D-PCR) with DHBV cccDNA-selective primers. The spe-
ciﬁc ampliﬁcation of cccDNA with cccDNA-selective primers was
veriﬁed previously [3]. 3D-PCR was performed as follows: initial
denaturation for 5 min at 94–83C, followed by 35 cycles of 30 s
at 94–83C, 30 s at 55C and 2 min at 72C, with a ﬁnal elongation
for 7 min at 72C. To determine the hypermutation frequency, PCR
fragments were cloned into T vectors (Promega, Madison, WI,
USA). Successfully recombined clones were randomly selected
and sequenced using ABI PRISM 3130 (Applied Biosystems, Foster
City, CA, USA).2.5. Southern blotting
Puriﬁed DHBV DNAs were analysed by Southern blotting using
double-stranded DHBV DNA probes spanning the entire viral gen-
ome. Probe labelling and signal development were performed
using the AlkPhos direct labelling system (GE Healthcare, Piscata-
way, NJ, USA), and signals were detected using the LAS 1000 ima-
ger system (GE Healthcare).
2.6. Rolling circle ampliﬁcation (RCA)
Speciﬁc ampliﬁcation of DHBV cccDNA by RCA method was de-
scribed previously [3,23]. The RCA concatemerized product was
converted to the monomeric full-length DHBV genome by diges-
tion with EcoRI, which cuts the DHBV cccDNA once. After electro-
phoresis, the DNA fragments were analysed by Southern blotting.
2.7. Western blotting
Transgene expression was analysed by Western blotting as de-
scribed previously [3]. The following antibodies were used in this
study: rabbit anti-GAPDH (G9545, Sigma), mouse anti-FLAG (M2,
Sigma), rabbit anti-ER (HC-20, Santa Cruz Biotechnology, CA,
USA) and anti-rabbit Igs-horseradish peroxidase (HRP) (ALI3404,
eBioscience, San Diego, CA, USA).
3. Results
3.1. Chicken AID induced cccDNA reduction via a UNG-dependent
pathway
A DHBV replication system in a chicken hepatoma cell line LMH
was utilized to analyse cccDNA. With this in vitro system, we could
detect cccDNA by Southern blotting of nuclear Hirt extracts
(Fig. 1A). The three DNA forms (re, dl and cccDNA) in the nuclear
Hirt extract were all converted into dlDNA position as 3.0-kb bands
after EcoRI digestion (Fig. 1A). To investigate the anti-DHBV activ-
ity of AID, a chicken AID expression vector and DHBV replicon plas-
mid pCSD3.5 were transfected into LMH cells. Concurrently, the
effect of UNG inhibition was also tested by co-transfection of a
UGI expression vector. UGI is an irreversible inhibitory protein that
forms a stable complex with UNG. We previously demonstrated a
91% reduction of UNG activity under the conditions shown in
Fig. 1B [3]. Six days after transfection, cytoplasmic nucleocapsid
(NC)-DNAs and nuclear Hirt-extracted DNAs were puriﬁed. South-
ern blotting showed that AID overexpression reduced DHBV
NC-DNA and cccDNA (Fig. 1B). UNG inhibition by UGI abolished
AID-induced reduction of cccDNA but not NC-DNA. We conﬁrmed
that the protein level of chicken AID was not affected by UGI over-
expression (Fig. 1C).
To determine cccDNA level at an earlier time point, we used
RCA, a highly sensitive method widely used to measure the level
of closed circular DNA of various viral species [24]. Three days after
transfection, cccDNA from nuclear Hirt-extracted DNAs was ampli-
ﬁed by RCA and digested with EcoRI to cleave the concatemer into
monomers of full-length viral genomes (3.0 kb). Ampliﬁed cccDNA
was detected by Southern blotting. Consistent with data obtained
from day 6 (Fig. 1B), AID overexpression reproducibly suppressed
both NC-DNA and cccDNA levels and UGI abolished the reduction
of only cccDNA at day 3 (Fig. 2A and B).
3.2. Chicken AID induced cccDNA hypermutation
Next, we investigated the hypermutation activity of AID for
DHBV cccDNA by 3D-PCR using cccDNA-speciﬁc primers
Fig. 1. Chicken AID induced DHBV cccDNA reduction depending on UNG activity. (A) Southern blotting for DHBV DNA. The DHBV replicon plasmid pCSD3.5DS was
transfected into LMH cells. Six days later, cells were harvested and cytoplasmic NC-DNA and nuclear Hirt-extracted DNA were puriﬁed. Nuclear sample without EcoRI
treatment showed two bands at the expected positions of relaxed circular (rc) DNA and cccDNA, respectively. Treatment with EcoRI (a single cutter for the DHBV genome)
resulted in conversion of both bands into one band at the position of double-stranded linear (dl) DNA. (B) Expression vectors for chicken AID-ER, UGI-ER and Mock-ER were
used to transfect LMH cells with pCSD3.5DS. The ER–fusion protein was expressed as an inactive form that could be activated by tamoxifen (OHT) treatment [22]. OHT was
added 3 days after transfection and cells were harvested at day 6. The cytoplasmic NC-DNA and nuclear Hirt-extracted DNA were puriﬁed from the indicated transfectants
and subjected to Southern blotting with a DHBV probe. The percent density of each band is indicated (top, rcDNA in NC; bottom, cccDNA in nucleus). The density of the
negative control (Mock-GFP) was deﬁned as 100%. (C) Exogenous protein expression of chicken AID- and Mock-ER was detected by Western blotting with anti-ER antibody.
pIRES-UGI was used to test whether UGI affects AID expression levels. Expression of GAPDH is also shown to demonstrate equivalent protein loading.
Fig. 2. Rolling circle ampliﬁcation (RCA) analysis of cccDNA. Three days after transfection (OHT stimulation for 2 days), cytoplasmic NC-DNA and nuclear Hirt-extracted DNA
were puriﬁed. (A) Southern blotting for the cytoplasmic NC-DNA. (B) Semi-quantiﬁcation by cccDNA-speciﬁc ampliﬁcation. The Hirt-extracted DNAs were serially diluted to
1:4 and 1:16 as shown in (B) and subjected to RCA with phi29 DNA polymerase. Concatemeric viral DNA were digested with EcoRI and analysed by Southern blotting.
Fig. 3. Chicken AID induced DHBV cccDNA hypermutation. (A) A schematic representation of cccDNA-selective primers. Left, cccDNA; right, rcDNA with gaps in both strands
(– and +), which leads to inefﬁcient ampliﬁcation of rcDNA with the cccDNA-selective primers [3]. (B) 3D-PCR analysis of DHBV cccDNA. The Hirt-extracted DNA from each
transfectant was analysed by 3D-PCR with a denaturation temperature (Td) gradient of 94.0, 85.3, 83.9 and 83.0C. PCR fragments (83.9C and 83C) indicated by triangles
were sequenced, and results from 4 independent clones are shown in C–E. (C) Mutation matrix of cccDNA from AID-UGI transfectants. (D) Proportion of G-to-A and C-to-T
mutations per clone. (E) Dinucleotide context analysis of C-to-T and G-to-A hypermutations. Underlined characters indicate mutated residues. The expected and observed
frequencies are shown in white and black bars, respectively.
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Fig. 5. Deletion of NES domain enhanced the cccDNA-reduction activity of chicken
AID. (A) Southern blotting for cytoplasmic NC-DNA and RCA-ampliﬁed cccDNA.
Three days after transfection (OHT stimulation for 2 days), DHBV DNAs were
analysed. (B) Exogenous protein expression of wild-type AID- and AIDDNES-ER was
detected by Western blotting with anti-ER antibody. Expression of GAPDH is also
shown to demonstrate equivalent protein loading.
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decreasing the denaturation temperature [25]. Our results showed
that only AID-UGI co-expression resulted in lower temperature
ampliﬁcation (83.9 and 83.0C, indicated by triangles in Fig. 3B).
Sequence analysis of DNA ampliﬁed at the lower denaturation
temperature revealed G-to-A and C-to-T hypermutations (Fig. 3C
and D and Fig. S1). Dinucleotide context analysis of the hypermu-
tated cccDNA showed a preference for GpC and ApC dinucleotides
as a mutation target (Fig. 3E), which is consistent with a previous
report of human AID-induced HBV hypermutation [10].
3.3. Chicken AID is a protein that shuttles between the cytoplasm and
nucleus
Chicken AID has a nuclear localization signal (NLS) in the N-ter-
minus and a nuclear export signal (NES) in the C-terminus [26]. To
determine the subcellular localization of chicken AID in chicken
hepatocytes, an AID-GFP vector was transfected into LMH cells.
Similar to human AID [27], chicken AID-GFP protein localized pre-
dominantly in the cytoplasm (Fig. 4A). Cells were treated with lep-
tomycin B (LMB) to inhibit exportin 1-dependent nuclear export
[27,28]. LMB treatment for 4 h changed the localization of AID from
the cytoplasm to both cytoplasm and nuclear. Consistent with this
observation, deletion of C-terminal residues containing NES
(AIDDNES in Fig. 4B, corresponding to JP8Bdel human mutant) re-
sulted in the nuclear localization of AID with minor cytoplasmic
retention (Fig. 4A). These observations indicate that chicken AID
shuttles between the cytoplasm and nucleus in LMH cells and that
the subcellular localization pattern of AID is conserved in mam-
mals and chicken.
3.4. Nuclear retention of AID enhanced cccDNA-reduction activity
Because the majority of AIDDNES-GFP protein was localized
mainly to the nucleus, we examined the cccDNA-reduction activity
of this mutant. Wild-type AID or AIDDNES was co-transfected with
a DHBV plasmid. Southern blotting following RCA showed that
AIDDNES had a stronger DHBV cccDNA-reduction activity than
wild-type AID, whereas reduction of cytoplasmic NC-DNA levels
by AIDDNES was slightly weaker than that by wild-type AIDFig. 4. Chicken AID is a protein that shuttles between the cytoplasm and nucleus.
(A) Chicken AID-GFP or AIDDNES-GFP was transfected into LMH cells. The nucleus
was visualized by co-transfection of the DsRed-NLS vector. LMB was treated for 4 h
to block nuclear export. LMB treatment caused accumulation of AID-GFP in the
nucleus. (B) Domain structure of chicken AID. Numbers indicate amino acid residue
positions. NLS, nuclear localization signal; NES, nuclear export signal.(Fig. 5A). Protein levels of AIDDNES were equivalent to that of
wild-type AID (Fig. 5B). These data suggest that nuclear-localized
AID is responsible for cccDNA reduction.
4. Discussion
In this study, we overexpressed chicken AID and inhibited UNG
activity in LMH cells to evaluate anti-viral roles of AID and UNG
against DHBV. We found that AID reduced both DHBV NC-DNA
and cccDNA levels, and UNG inhibition abolished the reduction
of cccDNA but not NC-DNA (Figs. 1 and 2). The UNG inhibition also
revealed the AID-induced G-to-A and C-to-T hypermutation in
cccDNA (Fig. 3). Furthermore, a nuclear-localized AID mutant more
strongly reduced cccDNA levels than wild-type AID (Fig. 5). These
results suggest that AID introduces C-to-U conversion in both
strands of cccDNA and that UNG-mediated BER may degrade urac-
ilated cccDNA (Fig. 6).
This study suggests that the molecular mechanism of AID-in-
duced NC-DNA reduction could be different from that for cccDNA
because it was found to be UNG-independent. We previously
showed a physical association between human AID and HBV core
proteins [11], suggesting the encapsidation of AID proteins in NC
as reported in the case of A3G. Unlike HIV, UNG incorporation
was not detected in HBV NC [3], implying no or little contributionFig. 6. A proposed model for AID-induced DHBV cccDNA reduction. Chicken AID
shuttles between the cytoplasm and nucleus. Cytoplasmic AID reduces NC-DNA
levels, presumably by an UNG-independent mechanism. Nuclear AID deaminates
cccDNA, and then uracilated cccDNA can be cleaved by the UNG-mediated BER
pathway. Previous HBV studies demonstrated that human AID hypermutates both
pgRNA and NC-DNA [10,11].
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A3G [29,30], AID may suppress NC-DNA formation through deam-
inase-independent activity such as inhibition of reverse transcrip-
tion. We also obtained the result, suggesting that human P19-AID
mutant carrying a mutation in the deaminase motif [31] has the
ability to reduce HBV NC-DNA as efﬁciently as wild-type AID
(unpublished). In contrast, when AID deaminates cccDNA in nu-
cleus, UNG-mediated BER can efﬁciently excise uracils from
cccDNA and cleave DNA, similar to the case of the immunoglobulin
gene undergoing CSR [13,18]. This can be a reason why cccDNA
reduction was abolished by UNG inhibition.
Our previous study revealed that A3G reduces both DHBV
cccDNA and NC-DNA [3]. In contrast to AID, cccDNA reduction by
A3G was not abolished when UNG was inhibited. It is likely that
AID has a different activity from A3G to suppress cccDNA. cccDNA
reduction by A3G may simply be reﬂected by the reduction of NC-
DNA, whereas de novo cccDNA degradation could be triggered by
nuclear-localized AID followed by UNG activity (Fig. 6). Enhance-
ment of cccDNA-reduction activity in the AIDDNES mutant
(Fig. 5) supports the idea that AID is directly targeted to nuclear
cccDNA. Furthermore, mutation analysis showed AID-induced
hypermutation in both strands of cccDNA (Fig. 3), which is differ-
ent from the A3G-induced hypermutation exclusively occurring
in the minus strand DNA [3]. cccDNA reduction mediated by the
AID/UNG pathway can be explained by double-strand breaks initi-
ated by deamination of both strands. AID is proposed to recruit
UNG to the immunoglobulin gene to cause CSR [32]. We speculate
that such a property may also underlie the different outcomes in
cccDNA reduction observed between AID and A3G.
Recently, Vartanian et al. clearly demonstrated that APOBEC3
proteins are major deaminases that cause HBV NC-DNA hypermu-
tation in vivo using dinucleotide context analysis of hypermutated
NC-DNA obtained from patients [10]. However, the contribution of
AID to cccDNA reduction and deaminase-independent NC-DNA
reduction was still unknown in vivo. Our data suggests cccDNA
as a novel target of the anti-HBV activity of AID for the ﬁrst time.
Further studies are required to reveal the mechanism of AID/
UNG-mediated HBV cccDNA degradation in vitro and in vivo.
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